当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:101.57亿  总市值:101.57亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,396,883,405.311,543,655,921.957,556,833,074.365,594,132,346.9
  收到的税费返还81,119,091.2555,507,842.04105,991,573.592,584,407.65
  收到其他与经营活动有关的现金67,922,075.1335,355,557.01198,454,535.84504,202,062.14
  经营活动现金流入小计3,545,924,571.691,634,519,3217,861,279,183.76,190,918,816.69
  购买商品、接受劳务支付的现金1,463,857,685668,605,567.423,294,331,239.882,604,852,414.66
  支付给职工以及为职工支付的现金643,990,753.35330,586,738.611,358,374,747.08977,258,465.26
  支付的各项税费271,039,830.5197,446,478.87495,020,001.28333,320,080.79
  支付其他与经营活动有关的现金675,538,245.92374,566,716.711,483,987,795.731,217,092,220.57
  经营活动现金流出小计3,054,426,514.781,471,205,501.616,631,713,783.975,132,523,181.28
  经营活动产生的现金流量净额491,498,056.91163,313,819.391,229,565,399.731,058,395,635.41
二、投资活动产生的现金流量:
  取得投资收益收到的现金60,000,00060,000,000710,914.98-
  处置固定资产、无形资产和其他长期资产收回的现金净额8,2006,9001,270,1711,256,500
  收到的其他与投资活动有关的现金--510,004,532.06-
  投资活动现金流入小计60,008,20060,006,900511,985,618.041,256,500
  购建固定资产、无形资产和其他长期资产支付的现金235,625,353.31120,585,892.86784,219,498.99481,875,355.35
  投资支付的现金--674,497,814.81-
  投资活动现金流出小计235,625,353.31120,585,892.861,458,717,313.8481,875,355.35
  投资活动产生的现金流量净额-175,617,153.31-60,578,992.86-946,731,695.76-480,618,855.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金7,000,000-903,000,000903,000,000
  其中:子公司吸收少数股东投资收到的现金--900,000,000-
  取得借款收到的现金3,490,450,0001,526,700,0009,793,745,0007,635,095,000
  收到其他与筹资活动有关的现金1,020,000,000449,650,0001,004,700,416.67707,360,000
  筹资活动现金流入小计4,517,450,0001,976,350,00011,701,445,416.679,245,455,000
  偿还债务支付的现金3,651,677,225.171,267,968,397.939,622,872,723.136,971,652,723.13
  分配股利、利润或偿付利息支付的现金257,176,839.4594,467,339.65492,581,063.47391,688,722.05
  其中:子公司支付给少数股东的股利、利润65,332,037.6323,514,00023,514,00022,102,000
  支付其他与筹资活动有关的现金1,122,652,095.72600,950,493.881,123,254,659.131,602,772,467.48
  筹资活动现金流出小计5,031,506,160.341,963,386,231.4611,238,708,445.738,966,113,912.66
  筹资活动产生的现金流量净额-514,056,160.3412,963,768.54462,736,970.94279,341,087.34
四、汇率变动对现金及现金等价物的影响3,877,130.092,527,048.3711,828,701.558,067,852.11
五、现金及现金等价物净增加额-194,298,126.65118,225,643.44757,399,376.46865,185,719.51
  加:期初现金及现金等价物余额1,262,403,953.021,262,403,953.02505,004,576.56505,004,576.56
  期末现金及现金等价物余额1,068,105,826.371,380,629,596.461,262,403,953.021,370,190,296.07
补充资料:
  净利润162,286,856.6-214,966,518.33-
  资产减值准备-7,432,452.04-16,374,073.77-
  固定资产和投资性房地产折旧326,705,415.13-635,679,352.84-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧326,705,415.13-635,679,352.84-
  无形资产摊销115,523,593.12-157,305,834.77-
  长期待摊费用摊销6,695,415.43-12,014,267.59-
  处置固定资产、无形资产和其他长期资产的损失9,846.67--444,156.56-
  固定资产报废损失--136,209.76-
  财务费用190,640,852.41-458,698,019.11-
  投资损失-26,285,765.54--46,164,658.18-
  递延所得税--8,779,495.24-
  其中:递延所得税资产减少---20,324,237.19-
    递延所得税负债增加--29,103,732.43-
  存货的减少201,726,632.27-94,320,345.95-
  经营性应收项目的减少-658,708,576.05-377,130,760.26-
  经营性应付项目的增加118,609,973.78--792,321,173.66-
  现金的期末余额1,068,105,826.37-1,262,403,953.02-
  减:现金的期初余额1,262,403,953.02-505,004,576.56-
  现金及现金等价物的净增加额-194,298,126.65-757,399,376.46-
公告日期2025-08-142025-04-242025-03-282024-10-26
审计意见(境内)标准无保留意见
TOP↑